Revolutionary Science Meets Transformative Cancer Therapy
Seattle Genetics is dedicated to improving patient outcomes with transformative therapies targeting cancer
From Promise to Therapy
Seattle Genetics is conducting clinical trials in these and other therapeutic areas:
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Urothelial cancer
- Breast cancer
Join The Seattle Genetics Team
We are a growing, mission-driven company with a culture built for passionate team players wanting to make a difference.
Recent News
Seattle Genetics At A Glance
| Size | Largest biotech in the Pacific Northwest |
|
| Global Headquarters | Bothell, WA |
|
| European Office | Zug, Switzerland |  |
| Number of Employees | 1,300+ |
|
| Public Company | Nasdaq:SGEN |
|
-
We’re excited to announce several presentations from multiple studies of novel targeted therapies at this year’s… twitter.com/i/web/status/1… · 3 days ago
-
We’re proud to honor @CancerCare’s 75 years of help and hope. Learn more about the impact CancerCare has made throu… twitter.com/i/web/status/1… · 2 weeks ago
-
We’ve received approval from Health Canada in frontline Hodgkin lymphoma and submitted for approval in frontline pe… twitter.com/i/web/status/1… · 2 weeks ago
